Signal2026-08-05
ClinicalTrials.gov

[PHASE2] GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD

Part of

Innovative Obesity And Metabolic Therapies

Open primary sourceSee the whole picture